Prospective, open-label trial measuring satisfaction and convenience of two formulations of lamotrigine in subjects with mood disorders

BACKGROUND: Lamotrigine is an anticonvulsant drug indicated for the maintenance treatment of bipolar I disorder and for various types of epilepsy. An orally disintegrating tablet (ODT) of lamotrigine was developed to provide a formulation option that might increase patient convenience and satisfacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sajatovic, Martha, Thompson, Thomas R, Nanry, Kevin, Edwards, Suzanne, Manjunath, Ranjani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653756/
https://www.ncbi.nlm.nih.gov/pubmed/23687443
http://dx.doi.org/10.2147/PPA.S40271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653756/
https://www.ncbi.nlm.nih.gov/pubmed/23687443
http://dx.doi.org/10.2147/PPA.S40271

Ejemplares similares